Was a great session and great to meet Marcelo Queiroz and Daniela A. Ferraro in person after reading their work for so many years!

Had a great SNMMI Mid Winter Meeting. Closed out the prostate session with an entertaining tumor board. So much variability in the use of FDG PET and conventional imaging during RLT treatment! Lisa Bodei, MD, PhD Amir Iravani

Amazing to see such a wonderful turnout. So much interest in education about PSMA PET and therapy.

Sorry for everyone who is virtually attending the PSMA conference - UCSF/UCLA/PCF/Urotoday as you miss out on the sunglasses!

So excited to have our nuclear medicine technologists so invested in PSMA PET and RLT. Hopefully meetings like this can help encourage more people to join the field. Keep it up E. Padilla-Morales!

An honor to have Charles Ryan kick off PSMA conference - UCSF/UCLA/PCF/Urotoday, and great to have the support and collaboration of Prostate Cancer Foundation

Can't believe RayzeBio was just purchased by BMS. It doesn't seem that long ago, having lunch with Deb Charych and Tom Harding at Beach Chalet, talking about what was to become AblateBio, and then RayzeBio. bit.ly/4axD1Vv

That is awesome news!

So proud of SurekhaYadav MD and her presentation at #RSNA23 . It's been amazing working with you this year, and excited to see where the future will take you. Hope everyone enjoyed her presentation on lesion dosimetry with 177Lu-PSMA-617 therapy.

The poster deadline for the UCSF/UCLA/PCF poster conference is December 1st.

Great work Michael Hofman! This figure is perfect. Not all targets are created equal. Going into my slide decks right now.

So excited to to finally see our trial of combining check point inhibitors (pembrolizumab) with a single dose of 177Lu-PSMA-617 finally get published in The Lancet Oncology. Great team work UCSF Helen Diller Family Comprehensive Cancer Ctr. Amazing PSA50 (56%) and duration of response with a single dose of RLT!